DECOMPENSATED CIRRHOSIS AND ASCITES
Clinical trials for DECOMPENSATED CIRRHOSIS AND ASCITES explained in plain language.
Never miss a new study
Get alerted when new DECOMPENSATED CIRRHOSIS AND ASCITES trials appear
Sign up with your email to follow new studies for DECOMPENSATED CIRRHOSIS AND ASCITES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cholesterol drug help slow liver failure?
Disease control Recruiting nowThis pilot study tests whether adding the statin atorvastatin to a standard beta blocker can help people with decompensated cirrhosis, a severe form of liver disease. Fifty participants will receive either atorvastatin plus their usual beta blocker or a placebo plus beta blocker,…
Matched conditions: DECOMPENSATED CIRRHOSIS AND ASCITES
Phase: PHASE2 • Sponsor: CAMC Health System • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a simple blood test make albumin therapy smarter for liver patients?
Disease control Recruiting nowThis study tests whether a biomarker can predict which people with advanced liver cirrhosis and fluid buildup (ascites) will benefit from regular albumin infusions. About 240 adults will receive either albumin or a placebo every 10 days for 6 months. The goal is to see if the bio…
Matched conditions: DECOMPENSATED CIRRHOSIS AND ASCITES
Phase: PHASE3 • Sponsor: Aleksander Krag • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC